Efficacy of Lauric Acid, a Dietary Fatty Acid, in Modifying the Latent Reservoir of HIV

Inclusion Criteria: * HIV-1 infected men or women ≥18 years old * Not having interrupted current antiretroviral treatment at least 6 months before the screening visit. * Acceptable stable ART regimens prior to screening include 2 more NRTIs: INI or NNRTI or boosted PI. * Documented prior evidence of at least 2 years prior to enrollment with a serum HIV RNA load of \<50 RNA copies/ml (viral load of \>50 copies but \<200 is allowed). * Plasma HIV-1 RNA \<50 c/ml at screening visit. * CD4 T cell count \> 300 cells/µL at screening visit. A woman may be eligible to enroll and participate in the study if: * Not pregnant, not of childbearing potential or physically unable to become pregnant * You are of childbearing potential with a negative pregnancy test at the screening visit and agree to use contraception to prevent pregnancy. Exclusion Criteria: * Have suffered any significant acute illness in the last 8 weeks. * Having been diagnosed in the past or present with an AIDS-defining illness * Previous CD4 T cell count \<200 cells/μL. * Having suffered an infection with Hepatitis B or C * Having any disease or condition that in the investigator's opinion is not appropriate for the patient's participation in the study.